ask="N/A"
ask_size="N/A"
average_daily_volume="167602"
bid="N/A"
bid_size="N/A"
book_value="3.69"
change="-0.45"
change_from_200_day_moving_average="0.89"
change_from_50_day_moving_average="-1.62"
change_from_52_week_high="-3.90"
change_From_52_week_low="6.82"
change_in_percent="-4.04%"
close="10.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.13"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-1.88"
ex_dividend_date="N/A"
float_shares="15630000"
high="11.15"
high_52_weeks="14.60"
last_trade_date="12/30/2016"
last_trade_price="10.70"
last_trade_size="13968"
last_trade_time="4:00pm"
low="10.65"
low_52_weeks="3.88"
market_capitalization="190.95M"
moving_average_200_day="9.81"
moving_average_50_day="12.32"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="28.25"
open="11.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+9.10%"
percent_change_from_50_day_moving_average="-13.18%"
percent_change_from_52_week_high="-26.71%"
percent_change_from_52_week_low="+175.77%"
previous_close="11.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.02"
price_per_sales="209.99"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="6.77"
stock_exchange="NCM"
symbol="STML"
volume="112033"
weeks_range_52="3.88 - 14.60"
